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Efﬁcient derivation of embryonic stem cells
from NOD-scid Il2rg−/− mice
Dear Editor,
For decades, the stem cell ﬁeld has pursued the develop-
ment of humanized mice to further enhance our under-
standing of human hematopoiesis, innate immunity,
infectious diseases, cancer biology and regenerative medi-
cine. One signiﬁcant breakthrough in generating humanized
mice was the development of NOD-scid Il2rg−/− mice, which
are double homozygous for the severe combined immun-
odeﬁciency (SCID) mutation and interleukin-2Rg (Il-2Rg)
allelic mutation (gamma c null) (Ito et al., 2002). The
immunodeﬁcient non-obese diabetic (NOD) genetic back-
ground contributes to deﬁciency in innate immunity with
impaired dendritic cell function and macrophage activity
(Shultz et al., 1995), and the Prkdc scid mutation leads to
elimination of adaptive immunity by loss-of-function of the
Prkdc gene, which encodes a protein critical for V(D)J
recombination in Tand B lymphocyte maturation (Blunt et al.,
1995). Moreover, the Il2rg−/− targeted mutation completely
deletes the interleukin 2 receptor gamma chain (Il2rg), a
common component of many cytokines involved in immune
function such as IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21,
making these mice extremely deﬁcient in NK cells which
enables xenotransplantation of human cells (Cao et al.,
1995). Combined, these immunodeﬁciency advantages
make NOD-scid Il2rg−/− mice excellent recipients to carry out
in vivo studies of human cells, tissues and organs, especially
for generating humanized mouse models, which can provide
insights into in vivo human biology and be utilized in many
pre-clinical research ﬁelds.
Although the NOD-scid Il2rg−/− mice are highly immun-
odeﬁcient and humanization on these mice has proved to be
a powerful and valuable model to in vivo study of human
disease, there are still some obvious defects in their appli-
cation for generating humanized mice. For example, NOD-
scid Il2rg−/− mice lack appropriate MHC molecules for T-cell
selection in the thymus and some human-speciﬁc cytokines
required for engrafted human cell development and survival.
Moreover, these mice also show low and variable levels of
T-cell-dependent antibody responses (Shultz et al., 2007).
These disadvantages might impede further application of
this humanized mouse model. However, one group recently
reported the acquisition of functional human embryonic stem
cells-derived thymic organoids in NOD-scid Il2rg−/− mice,
providing valuable clues about the maturation process of
engrafted human T cells (Sun et al., 2013). In addition,
another alternative way to develop more adaptive human-
ized mouse models is to introduce genes, which encode
human speciﬁc HLA and cytokines critical for engrafted
human T cell selection and survival, to the genome of NOD-
scid Il2rg−/− mice (Shultz et al., 2007). However, this strategy
still requires further genomic editing that heavily relies on the
establishment of pluripotent stem cells from this mouse
strain. To this end, here we report efﬁciently establishing
embryonic stem cell lines possessing in vitro and in vivo
pluripotency from NOD-scid Il2rg−/− mice.
To derive NOD-scid Il2rg−/− embryonic stem cell lines, a
total of 28 blastocysts were recovered from NOD-scid Il2rg−/−
mice (NPGTM, VITALSTAR) and cultured on MEF (mouse
embryonic ﬁbroblasts) feeder cells under N2/B27 medium
supplemented with the 2i/LIF, which was previously reported
for use in harvesting and culturing rodent pluripotent stem
cells (Ying et al., 2008). After 5 to 8 days, these 28 blasto-
cysts were successfully cultured and showed outgrowths
(Fig. 1B). These outgrowths were manually picked up and
single-cell passaged by accutase, and replated onto MEF
feeder cells. Since vitamin C has proved to play positive
roles in promoting reprograming and maintaining pluripo-
tency (Esteban and Pei, 2012; Shi et al., 2010), it was added
into the 2i/LIF culture medium for long-term cultivation. After
several passages, we successfully established 14 ES cell
lines from the 28 blastocysts (Fig. 1B).
All 14 ES cell lines showed dome-shaped colonies with
smooth boundaries (Fig. 1A) and we chose 3 ES cell lines
(referred to as NPG-ESCs) for further analysis. These NPG-
ESCs had normal karyotypes (40, XY for male) and main-
tained alkaline phosphatase (AP) activity for more than 15
passages (Fig. 1A and 1F). They also grew with a doubling
time similar to those of TT2 mouse embryonic stem cells
(mESCs) and chemically induced pluripotent stem cells
(CiPSCs) that have been established previously (Hou et al.,
2013) (Fig. 1E). Moreover, the pluripotent characteristics of
the NPG-ESCs were further examined by immunostaining
and reverse-transcription (RT)-PCR. Speciﬁcally, NPG-
ESCs were positively stained for pluripotency-speciﬁc
mESCs and iPSCs markers, including Oct4, Sox2, Nanog
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and SSEA-1 (Fig. 1C). RT-PCR analysis showed that the
NPG-ESCs also expressed typical pluripotency marker
genes, such as Oct4, Sox2, Nanog, Rex1 and Klf4 (Fig. 1D).
Further genomic PCR of 2 NPG-speciﬁc mutant gene sites
Il2rg and Prkdc showed that both the 2 NPG ESC lines
possessed NPG speciﬁc mutations at these sites (Fig. S1).
Thus, these results indicate that the NPG-ESCs possess
self-renewal and pluripotent characteristics in vitro.
To further evaluate the differentiation potential of the
NPG-ESC lines, we tested their capacity to differentiate into
cell types of the three germ layers. All three NPG-ESC lines
chosen formed teratomas comprised of tissues from all three
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Figure 1. Derivation of embryonic stem cells from NOD-scid Il2rg−/− (NPG) mice. (A) Representative images of outgrowth
expanded from NOD-scid Il2rg−/− blastocysts (left), day-2 ESC colonies after single-cell passaging (middle), day-2 ESC colonies after
AP staining. Scale bar, 100 μm (B) Summary of the efﬁciency of NPG-ESC lines derivation from 2 separate experiments. Black
columns: total blastocysts derived; Grey columns: NPG-ESC lines derived. (C) Representative images of NPG-ESC colonies
immunostained for Oct4, Sox2, Nanog and SSEA-1. Scale bars, 100 μm. (D) RT-PCR analysis of pluripotency gene expression in
NPG-ESCs. (NPG-3, NPG-4, NPG-5: three independently established NPG-ESC lines; J1 and C57/B6: mouse ESC lines; CiPS:
chemical induced pluripotent stem cell line; MEF: mouse embryonic ﬁbroblasts) (E) Growth curve of 2 NPG-ESC lines, 1 ESC line and
1 CiPSC line. Cells were harvested and counted at indicated time points. Starting cell number: 1 × 105; 3 well replicates (F) Karyotype
analysis showing the normal karyotypes of NPG-ESCs at passage 15 (G) In vivo teratoma differentiation of NPG-ESCs. The cells
gave rise to well-differentiated mature teratomas with cells from all the three germ lineages, ectoderm, mesoderm and endoderm.
Scale bars, 100 μm. (H) Chimeric mice derived from injecting C57/B6 8 cell embryos with NPG-ESCs. Yellow arrowheads indicate 2
chimeric offspring.
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germ layers in vivo 4–5 weeks after injection into recipient
mice (Fig. 1G). In addition, these NPG-ESCs were efﬁciently
incorporated into the inner cell masses of mouse blastocysts
after aggregation with eight-cell embryos. Chimeric embryos
further developed into adult mice with high degrees of chi-
merism (Fig. 1H). Thus, these results indicate that the NPG-
ESCs can fully develop and differentiate in vivo to form three
germ layers and generate chimeric mice with germ-line
contribution.
In summary, our ﬁndings provide an effective system to
derive embryonic stem cell lines from NOD-scid Il2rg−/−
mice. Moreover, unlike the traditional 2i/Lif condition which
could only support NPG ESCs at early passages (Table S1),
our new culture condition allows long-term maintenance of
the self-renewal circuitry of NOD-scid Il2rg−/− ESCs with
normal karyotypes and in vitro and in vivo pluripotency.
Efﬁciently establishing stable NOD-scid Il2rg−/− ESC lines
will also offer a constant and easy-to-access platform to
develop new, superior humanized mouse models by further
modifying the genes encoding HLA and cytokines through
CRISPR/CAS9 technology in NOD-scid Il2rg−/− mice, which
will be powerful tools in pre-clinical testing and in vivo
studies of human diseases and biological processes (Cong
and Zhang 2015).
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